Article Text

Download PDFPDF

Correction: Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma

Statistics from Altmetric.com

Reschke R, Yu J, Flood B, et al. Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma. J ImmunoTher Cancer 2021;9:e003521. doi: 10.1136/jitc-2021-003521

This article has been corrected since it was first published. The middle initial has been added to author name ‘Blake A Flood’.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.